A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharmas clinical study with CDNF in Parkinsons disease authorized in Sweden

Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Sweden Herantis Pharma PlcCompany release 23 March 2017 at…

Read More

Herantis Pharma's Annual Report 2016 published

Herantis Pharma's Annual Report 2016 published Herantis Pharma Plc Company release 17 March 2017 at 9:00 am Herantis Pharma Plc's…

Read More

Herantis Pharma's clinical study with Lymfactin advances to high dose level

Herantis Pharma's clinical study with Lymfactin advances to high dose level Herantis Pharma Plc Company release 6 March 2017 at…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.